Some researchers have reported that α-SMA is widely expressed in CAFs or myofibroblasts and that expression of α-SMA is associated with poor prognosis of patients with various types of cancers, including OSCC [29,30,31,32,33]. This evidence concerns the gene ACTA1 and cancer.